Cabonni (Cabozantinib) 20mg/80mg | Multi-Kinase Inhibitor | Trans Continental Life Science & Pharmaceuticals (TLPH) | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Share
Product description

Cabonni is a generic cabozantinib produced by Trans Continental Life Science & Pharmaceuticals (TLPH) in Laos. This listing supplies both the 20 mg and 80 mg capsule strengths, the two building blocks used to reach the drug's two standard daily doses.

Generic Information: Cabonni (Cabozantinib)

Trans Continental Life Science & Pharmaceuticals (TLPH) is a Lao pharmaceutical manufacturer serving the domestic market and regional export channels. Cabonni is its cabozantinib brand, containing the same active ingredient as the originator Cometriq and Cabometyx. The dual-strength listing covers the full dosing spectrum of this multi-kinase inhibitor.

What Is Cabonni (Cabozantinib) Used For?

Cabonni treats medullary thyroid cancer, renal cell carcinoma, hepatocellular carcinoma, differentiated thyroid cancer and neuroendocrine tumors. The two strengths are combined to deliver the dose appropriate to each indication.

How Does Cabonni Work?

The cabozantinib in Cabonni inhibits MET, VEGFR-2, RET, AXL, KIT and FLT-3, suppressing tumor growth, reducing the blood-vessel formation tumors depend on, and limiting metastasis. This reproduces the originator's multi-kinase mechanism.

Indications

  • Progressive, metastatic medullary thyroid cancer
  • Advanced renal cell carcinoma
  • Hepatocellular carcinoma after sorafenib
  • Differentiated thyroid cancer refractory to radioactive iodine
  • Well-differentiated neuroendocrine tumors

Dosage & Administration

Medullary thyroid cancer uses 140 mg daily, made from 80 mg and 20 mg capsules; other indications use 60 mg daily. Both strengths in this listing support these regimens. Capsules are swallowed whole with water.

Side Effects

Diarrhea, fatigue, nausea, decreased appetite, hand-foot skin reaction and hypertension are common. Serious risks include severe bleeding, gastrointestinal perforation, blood clots, heart problems and osteonecrosis of the jaw. Monitoring of blood pressure and liver function is required.

Storage & Handling

Store at room temperature in the original packaging, protected from moisture and light, out of children's reach, and not past expiry.

Why Choose Cabonni?

  • Both strengths available — 20 mg and 80 mg in one listing.
  • TLPH manufacturer — a Lao pharmaceutical producer.
  • Affordable — lower-cost cabozantinib for multiple indications.

How to Order Cabonni from GLT

  1. Contact GLT via WhatsApp +86 15234153837 or email [email protected].
  2. Receive a quotation and delivery estimate.
  3. Pay via Hao Yi Lian / 好易联.
  4. Dispatch with documentation and tracking.

A valid prescription may be requested before dispatch. Institutions and individual patients are served.

FAQ

1. What strengths does Cabonni come in?

Cabonni is available as 20 mg and 80 mg capsules.

2. Who manufactures Cabonni?

Cabonni is manufactured by Trans Continental Life Science & Pharmaceuticals (TLPH) in Laos.

3. Do I need a prescription?

Yes, cabozantinib is prescription-only.

Related Oncology Products

LuciAvat (Avatrombopag) 20mg*28 Tablets | Lucius Pharmaceuticals Laos | GLT

LuciAvat — avatrombopag 20mg (23.6mg maleate) film-coated tablets by Lucius Pharmaceuticals (Lao) Co., Ltd., Vientiane

Barinib (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Drug International Limited | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Drug International Limited (Bangladesh) — an affordable alternative to Olumiant...

Rizonib (Crizotinib) 250mg Capsules | DIL Bangladesh Generic Xalkori for ALK+ NSCLC | GLT

Rizonib 250 by Drug International Ltd (DIL), Tongi Gazipur — affordable crizotinib generic from Bangladesh

KangQuXin 康曲欣 (Avatrombopag) 20mg*10 Tablets | Beijing Continent Gyre | GLT

KangQuXin — avatrombopag by Beijing Continent Pharmaceutical (Gyre Therapeutics, Nasdaq: GYRE), China Mainland

KeZeRui 科瑞泽 (Avatrombopag) 20mg*10 Tablets | Sichuan Kelun China | GLT

KeZeRui — national-procurement avatrombopag from Sichuan Kelun Pharmaceutical, China's integrated API + tablet maker

Avabopa (Avatrombopag) 20mg*30 Tablets | Tongmeng TLPH Laos | GLT

Avabopa — avatrombopag 20mg by Tongmeng (Lao) Pharmaceutical and Food Co., Ltd. (TLPH), Lao Reg....

Olumiant (Baricitinib) 2mg/4mg Tablets | JAK1/JAK2 Inhibitor | Eli Lilly USA | GLT

Eli Lilly's selective JAK1/JAK2 inhibitor for rheumatoid arthritis, atopic dermatitis and severe alopecia areata.

Orforglipron (LuciOrfor) 0.8–17.2mg Tablets | Laos Generic Oral GLP-1 | GLT

Lucius Pharmaceuticals (Laos) generic orforglipron, 6-dose titration for weight management